Barclays’s Cerebras Systems CBRS Stock Holding History

Barclays’s Portfolio CBRS Stock Details CBRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$97.3M	Buy	547,909 +529,908	+2,944%	+$107M	0.02%	507
2026 Q2	$3.98M	Buy	+18,001	New	+$4.24M	﹤0.01%	1960

Other funds holding CBRS

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Eclipse Ventures Palo Alto, California $981M AUM 64.81% 1-Year Est. Return

Alpha Wave Global New York $4.27B AUM 12.79% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Washington University St Louis, Missouri $524M AUM 34.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Barclays's CBRS Position: Q3 2026 in Review

Barclays increased its Cerebras Systems (CBRS) stake by 2,944% in Q3 2026, buying an estimated $107M and bringing the position to 547,909 shares worth $97.3M. The position accounts for 0.02% of the portfolio, ranked #507.

Barclays first reported a position in CBRS in Q2 2026 and has held it in 2 quarters since. 417 funds tracked by Wall St. Rank hold CBRS as of Q3 2026.

Barclays held 547,909 shares of Cerebras Systems worth $97.3M as of Q3 2026.
Barclays bought 529,908 Cerebras Systems shares in Q3 2026, an estimated $107M.
Cerebras Systems made up 0.02% of Barclays's portfolio in Q3 2026, its #507 holding.
Barclays first reported a position in Cerebras Systems in Q2 2026 and has held it in 2 quarters since.
417 funds tracked by Wall St. Rank held Cerebras Systems as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.